[Remote] Medical Science Liaison - Breast Oncology (West Coast) at Natera

United States

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Scientific communicationBreast oncologyMolecular diagnosticsClinical researchRelationship managementScientific presentationKey Opinion Leader engagementClinical trial coordination

Questions & Answers

Common questions about this position

What is the salary range for the Medical Science Liaison position?

The salary range is $145,000 - $170,000 USD.

Is this Medical Science Liaison role remote, and what is the territory?

The position is remote within the USA, with a territory covering the West Coast, and candidates must reside within the assigned territory.

What qualifications and skills are required for this MSL role?

An advanced scientific/healthcare degree preferred (Ph.D., Pharm.D., M.D., D.N.P.); Master’s degree required, relevant knowledge in breast oncology, excellent communication skills, ability to build relationships, and work independently in a remote setting.

What is the work environment like for this position?

The role is remote with extensive travel (>60%), requires independent work while maintaining teamwork, and involves a fast-paced environment with competing priorities.

What makes a strong candidate for this Medical Science Liaison role?

Candidates with an advanced degree (Ph.D., Pharm.D., M.D., D.N.P.), prior MSL experience, deep expertise in breast oncology, strong relationship-building skills, and ability to reside in the West Coast territory stand out.

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free